Eli Lilly
How Eli Lilly’s $3.25 Billion Acquisition of Kelonia Therapeutics Marks a Turning Point in the Startup’s Challenging Journey
Eli Lilly has announced a significant move: they are acquiring Kelonia Therapeutics for $3.25 billion. This small biotech firm specializes ... Read more
Breaking News: Eli Lilly’s Weight-Loss Pill for Obesity Receives Fast-Track FDA Approval!
Federal regulators have approved Eli Lilly’s new weight-loss pill, orforglipron, also known as Foundayo. This is a significant development in ... Read more
Asian Markets Surge as Optimism Grows for End of Iran Conflict
Asian stocks saw a big boost on Wednesday, following a strong performance from U.S. markets. Optimism is rising that the ... Read more
Ozempic Enters the Generic Market—But Why Is It Still Unavailable in the US?
A drug called semaglutide, known as Ozempic and Wegovy, has helped make Novo Nordisk the most valuable company in Europe. ... Read more
Unpacking the Controversy: Key Legal Questions Surrounding the FDA’s New Fast-Track Drug Approval Program
There’s growing concern within the FDA about a new program aimed at speeding up drug reviews. This initiative, backed by ... Read more
Trump’s New Import Taxes: What You Need to Know About Rising Prices on Pharmaceuticals, Furniture, and Heavy Trucks
President Announces Major Tariffs on Imports President Donald Trump revealed he plans to impose hefty import taxes on various products ... Read more
Viking Therapeutics Shares Plummet 37% Amid High Dropout Rates in Obesity Trial: What You Need to Know
Viking Therapeutics (NASDAQ:VKTX) saw its stock drop by 37% recently after sharing results from its Phase 2 VENTURE trial for ... Read more
